Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.07 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.07 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.31 | 0.08 |
mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.08 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.08 |
mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |